Citation: | CHEN Xiao-qing, DING Ping-gang, XU Ru-ling, DONG Hui-min, QI Zhi-chao, JU Jian-ming. Honokiol Loaded Mixed Micelles Fororal Delivery Using Novel F127 and TPGS as Carriers[J]. Journal of Nanjing University of traditional Chinese Medicine, 2021, 37(3): 376-382. doi: 10.14148/j.issn.1672-0482.2021.0376 |
[1] |
PRASAD R, KATIYAR SK. Honokiol, an active compound of Magnolia plant, inhibits growth, and progression of cancers of different organs[J]. Adv Exp Med Biol, 2016, 928: 245-265. doi: 10.1007/978-3-319-41334-1_11
|
[2] |
LEE YJ, LEE YM, LEE CK, et al. Therapeutic applications of compounds in the Magnolia family[J]. Pharmacol Ther, 2011, 130(2): 157-176. doi: 10.1016/j.pharmthera.2011.01.010
|
[3] |
GOWDA AS, SUO ZC, SPRATT TE. Honokiol inhibits DNA polymerases β and λ and increases bleomycin sensitivity of human cancer cells[J]. Chem Res Toxicol, 2017, 30(2): 715-725. doi: 10.1021/acs.chemrestox.6b00451
|
[4] |
SENGUPTA S, NAGALINGAM A, MUNIRAJ N, et al. Activation of tumor suppressor LKB1 by honokiol abrogates cancer stem-like phenotype in breast cancer via inhibition of oncogenic Stat3[J]. Oncogene, 2017, 36(41): 5709-5721. doi: 10.1038/onc.2017.164
|
[5] |
PAN J, LEE Y, WANG YA, et al. Honokiol targets mitochondria to halt cancer progression and metastasis[J]. Mol Nutr Food Res, 2016, 60(6): 1383-1395. doi: 10.1002/mnfr.201501007
|
[6] |
DENG F, HU WJ, CHEN HL, et al. Development of a chitosan-based nanoparticle formulation for ophthalmic delivery of honokiol[J]. Curr Drug Deliv, 2018, 15(4): 594-600. doi: 10.2174/1567201814666170419113933
|
[7] |
DESHMANE S, DESHMANE S, SHELKE S, et al. Enhancement of solubility and bioavailability of ambrisentan by solid dispersion using Daucus carota as a drug carrier: formulation, characterization, in vitro, and in vivo study[J]. Drug Dev Ind Pharm, 2018, 44: 1001-1011. doi: 10.1080/03639045.2018.1428339
|
[8] |
SALMANI JM, LYU H, ASGHAR S, et al. Amorphous solid dispersion with increased gastric solubility in tandem with oral disintegrating tablets: A successful approach to improve the bioavailability of atorvastatin[J]. Pharm Dev Technol, 2015, 20: 465-472. doi: 10.3109/10837450.2014.882938
|
[9] |
WANG WQ, CUI CC, LI MY, et al. Study of a novel disintegrable oleanolic acid-polyvinylpolypyrrolidone solid dispersion[J]. Drug Dev Ind Pharm, 2017, 43(7): 1178-1185. doi: 10.1080/03639045.2017.1301950
|
[10] |
DENG J, ZHANG Z, LIU C, et al. The studies of N-Octyl-N-Arginine-Chitosan coated liposome as an oral delivery system of Cyclosporine A[J]. J Pharm Pharmacol, 2015, 67: 1363-1370. doi: 10.1111/jphp.12448
|
[11] |
ARAFAT M, KIRCHHOEFER C, MIKOV M, et al. Nanosized liposomes containing bile salt: A vesicular nanocarrier for enhancing oral bioavailability of BCS class Ⅲ Drug[J]. J Pharm Pharm Sci, 2017, 20: 305-318. doi: 10.18433/J3CK88
|
[12] |
WANG M, LIU M, XIE T, et al. Chitosan-modified cholesterol-free liposomes for improving the oral bioavailability of progesterone[J]. Colloids Surf B Biointerfaces, 2017, 159: 580-585. doi: 10.1016/j.colsurfb.2017.08.028
|
[13] |
FARES AR, ELMESHAD AN, KASSEM MAA. Enhancement of dissolution and oral bioavailability of lacidipine via pluronic P123/F127 mixed polymeric micelles: Formulation, optimization using central composite design and in vivo bioavailability study[J]. Drug Deliv, 2018, 25(1): 132-142. doi: 10.1080/10717544.2017.1419512
|
[14] |
HALLAN SS, KAUR P, KAUR V, et al. Lipid polymer hybrid as emerging tool in nanocarriers for oral drug delivery[J]. Artif Cells Nanomed Biotechnol, 2016, 44: 334-349. doi: 10.3109/21691401.2014.951721
|
[15] |
TANG L, FU LL, ZHU ZF, et al. Modified mixed nanomicelles with collagen peptides enhanced oral absorption of Cucurbitacin B: Preparation and evaluation[J]. Drug Deliv, 2018, 25(1): 862-871. doi: 10.1080/10717544.2018.1425773
|
[16] |
ZHANG ZH, WANG XP, AYMAN WY, et al. Studies on lactoferrin nanoparticles of gambogic acid for oral delivery[J]. Drug Deliv, 2013, 20: 86-93. doi: 10.3109/10717544.2013.766781
|
[17] |
MA CL, PAN PJ, SHAN GR, et al. Core-shell structure, biodegradation, and drug release behavior of poly(lactic acid)/poly(ethylene glycol) block copolymer micelles tuned by macromolecular stereostructure[J]. Langmuir, 2015, 31(4): 1527-1536. doi: 10.1021/la503869d
|
[18] |
FARES AR, ELMESHAD AN, KASSEM MAA. Enhancement of dissolution and oral bioavailability of lacidipine via pluronic P123/F127 mixed polymeric micelles: Formulation, optimization using central composite design and in vivo bioavailability study[J]. Drug Deliv, 2018, 25(1): 132-142. doi: 10.1080/10717544.2017.1419512
|
[19] |
HOU J, WANG J, SUN E, et al. Preparation and evaluation of icariside Ⅱ-loaded binary mixed micelles using Solutol HS15 and Pluronic F127 as carriers[J]. Drug Deliv, 2016, 23(9): 3248-3256. doi: 10.3109/10717544.2016.1167270
|
[20] |
ZHANG ZH, CHEN Y, DENG J, et al. Solid dispersion of berberine-phospholipid complex/TPGS 1000/SiO2: Preparation, characterization and in vivo studies[J]. Int J Pharm, 2014, 465(1/2): 306-316. http://www.onacademic.com/detail/journal_1000036238726610_806e.html
|
[21] |
ZHAO J, XU Y, WANG C, et al. Soluplus/TPGS mixed micelles for dioscin delivery in cancer therapy[J]. Drug Dev Ind Pharm, 2017, 43: 1197-1204. doi: 10.1080/03639045.2017.1304956
|
[22] |
ZHAO DJ, ZHANG HY, YANG SF, et al. Redox-sensitive mPEG-SS-PTX/TPGS mixed micelles: An efficient drug delivery system for overcoming multidrug resistance[J]. Int J Pharm, 2016, 515(1/2): 281-292. http://www.onacademic.com/detail/journal_1000039666745410_41ef.html
|
[23] |
ZHANG J, FANG X, LI Z, et al. Redox-sensitive micelles composed of disulfide-linked Pluronic-linoleic acid for enhanced anticancer efficiency of brusatol[J]. Int J Nanomedicine, 2018, 13: 939-956. doi: 10.2147/IJN.S130696
|
[24] |
FARES AR, ELMESHAD AN, KASSEM MAA. Enhancement of dissolution and oral bioavailability of lacidipine via pluronic P123/F127 mixed polymeric micelles: Formulation, optimization using central composite design and in vivo bioavailability study[J]. Drug Deliv, 2018, 25(1): 132-142. doi: 10.1080/10717544.2017.1419512
|
[25] |
BRANCA C, KHOUZAMI K, WANDERLINGH U, et al. Effect of intercalated chitosan/clay nanostructures on concentrated pluronic F127 solution: A FTIR-ATR, DSC and rheological study[J]. J Colloid Interface Sci, 2018, 517: 221-229. doi: 10.1016/j.jcis.2018.02.004
|
[26] |
GUAN YB, HUANG JG, ZUO L, et al. Effect of pluronic P123 and F127 block copolymer on P-glycoprotein transport and CYP3A metabolism[J]. Arch Pharm Res, 2011, 34(10): 1719-1728. doi: 10.1007/s12272-011-1016-0
|
[27] |
WEI Z, YUAN S, HAO J, et al. Mechanism of inhibition of P-glycoprotein mediated efflux by Pluronic P123/F127 block copolymers: relationship between copolymer concentration and inhibitory activity[J]. Eur J Pharm Biopharm, 2013, 83: 266-274. doi: 10.1016/j.ejpb.2012.09.014
|
[28] |
PAWAR A, SINGH S, RAJALAKSHMI S, et al. Development of fisetin-loaded folate functionalized pluronic micelles for breast cancer targeting[J]. Artif Cells Nanomed Biotechnol, 2018, 46(S1): 347-361. doi: 10.1080/21691401.2018.1423991
|
[29] |
CHEN CH, CHIANG CJ, WU LC, et al. In vitro penetration and in vivo distribution of honokiol into the intervertebral disc in rat[J]. Anal Sci, 2015, 31(12): 1297-1302. doi: 10.2116/analsci.31.1297
|
[30] |
LI X, HOU X, DING W, et al. Sirolimus-loaded polymeric micelles with honokiol for oral delivery[J]. J Pharm Pharmacol, 2015, 67: 1663-1672. doi: 10.1111/jphp.12482
|
[31] |
KANADE R, BOCHE M, POKHARKAR V. Self-assembling raloxifene loaded mixed micelles: Formulation optimization, in vitro cytotoxicity and in vivo pharmacokinetics[J]. AAPS Pharm Sci Tech, 2018, 19(3): 1105-1115. doi: 10.1208/s12249-017-0919-6
|
[32] |
ZHANG ZH, LYU H, JIA XB, et al. Influence of vitamin E tocopherol polyethylene glycol succinate 1 000 on intestinal absorption of icariside Ⅱ[J]. Pharmazie, 2012, 67(1): 59-62. http://www.ncbi.nlm.nih.gov/pubmed/22393832
|
[33] |
LIU Y, WANG D, YANG G, et al. Comparative pharmacokinetics and brain distribution of magnolol and honokiol after oral administration of Magnolia officinalis cortex extract and its compatibility with other herbal medicines in Zhi-Zi-Hou-Po Decoction to rats[J]. Biomed Chromatogr, 2016, 30: 369-375. doi: 10.1002/bmc.3557
|
[34] |
GODUGU C, DODDAPANENI R, SINGH M. Honokiol nanomicellar formulation produced increased oral bioavailability and anticancer effects in triple negative breast cancer (TNBC)[J]. Colloids Surf B Biointerfaces, 2017, 153: 208-219. doi: 10.1016/j.colsurfb.2017.01.038
|
[35] |
WANG XH, CAI LL, ZHANG XY, et al. Improved solubility and pharmacokinetics of PEGylated liposomal honokiol and human plasma protein binding ability of honokiol[J]. Int J Pharm, 2011, 410(1/2): 169-174. http://www.onacademic.com/detail/journal_1000034021473310_66d8.html
|